Stocktoria
Envoy Medical, Inc. COCH
Envoy Medical, Inc. (COCH) earns a Piotroski F-score of 2/9 (weak financial health). It pays a dividend yielding 3.55% (safety: safe). FY2025 revenue was $241,000 at a -9857.3% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| COCH | Envoy Medical, Inc. | 2/9 | — | — | — |
| CUPR | Cuprina Holdings (Cayman) LTD | 4/9 | -2.57 | — | — |
| HSCS | HeartSciences Inc. | 1/9 | — | — | — |
| SPAI | Safe Pro Group Inc. | 4/9 | 9.05 | — | — |
| AVR | Anteris Technologies Global Corp. | 2/9 | — | — | — |
| NTRB | NutriBand Inc. | 3/9 | -15.84 | — | — |
| CLGN | CollPlant Biotechnologies Ltd | 3/9 | — | — | — |
About Envoy Medical, Inc.
Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
FAQ
Is COCH financially healthy?
Envoy Medical, Inc.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).
Does COCH pay a dividend, and is it safe?
Yes. Envoy Medical, Inc. pays a dividend yielding about 3.55% with a -7.7% payout ratio, rated “safe” for safety.
How profitable is COCH?
In FY2025, Envoy Medical, Inc. had a net margin of -9857.3%.
What is the analyst price target for COCH?
The average Wall-Street price target for Envoy Medical, Inc. is $2.50, about 235.4% above the recent price, from 1 analysts.
Is COCH a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Envoy Medical, Inc.: a Piotroski F-score of 2/9, a dividend yield of 3.55%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.